The Link Between Periodontitis, Smoking and Oral Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCairo University

About this trial

Periodontitis is a widely prevalent disease worldwide that has serious public health consequences. Its prognosis includes tooth loss and edentulism, a condition that negatively affects chewing causing functional disability; and esthetics causing social impairment. Consequently, periodontitis may end up causing marked impairment of the quality of life of the affected patients, impairment of general health and increasing the dental care costs significantly.

Changes in the oral mucosa arise by primary products resulting from tissue breakdown due to gingivitis. It then triggers the host cells to produce proteinases that mediate loss of marginal periodontal ligaments, apical migration of the junctional epithelium and apical spread of bacterial biofilm.

Therefore, this research aims to identify the risk of smoking to both periodontitis and oral cancer, and the risk of periodontitis to oral cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients 18 years or older.

Disqualifiers

Patients with any systemic diseases.

Pregnant females.

Handicapped and mentally retarded patients.

Patients undergoing radiotherapy.

Trial population

Adult individuals

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • biopsy for oral cancer

    Diagnostic test

    surgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions

  • periodontal examination

    Diagnostic test

    Periodontal clinical examination to all by periodontal charting

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Smokers2 interventions
Group B: non-Smokers2 interventions

Trial outcomes

Primary outcomes

1

Periodontitis

arising of periodontitis or increase in the grade of an already existing case of periodontitis

Time frame
the 10 years of the study

Secondary outcomes

1

Oral cancer

Arising of a lesion of oral cancer or a premalignant lesion

Time frame
the 10 years of the study

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: